Current ASH Scholars
Transfers
In the event the scholar transfers to another institution during the funding period, continuation of the funding at the new institution may be allowed with prior approval from the Society. To obtain permission, the scholar must make a request in writing to the Society before the transfer occurs.
Reallocation of Funds
Scholars may request a reallocation of funds from one expense category to another by submitting the request in writing to the Treasurer at the Society’s headquarters. This written request must specify the dollar amount, which categories are impacted, and a justification as to why this change is necessary.
All transfer and/or rebudgeting requests must be sent to the attention of Elisa Shea at ASH Headquarters, who will work with the ASH Treasurer to make final determinations.
Progress Reports
Scholar Award recipients are required to submit annual progress reports to the Society. The progress reports include a summary of the work performed and reprints of publications written by the scholar during the term of the award. This must be a two-page summary of the work accomplished in the first year of the award. This summary should be accompanied by a letter from the scholar’s Division Head or Department Chair requesting the second year of funding. It should also provide assurances that the scholar’s work has progressed and that both appropriate facilities and the scholar’s mentor will continue to be available to the scholar. Failure to submit the progress report after the first year will render the scholar ineligible for the second year of funding. The recipients will be expected to cite support from the American Society of Hematology in any publication describing research conducted during the period of the award.
Final Reports
A final written report (not to exceed five pages) is expected within 30 days of the end of the award period. Scholar Award recipients, along with the financial officers from their institutions, must also submit a financial report detailing how the funds were used over the two- or three-year period. This report must be sent to ASH Headquarters to the attention of Elisa Shea within 60 days of the end of the award period.
2009 Scholar Award Winners Announced
ASH is proud to announce the newest class of ASH Scholars. ASH received many applications of extremely high quality this past year. The following individuals submitted outstanding applications and we congratulate them on their success. We look forward to great things from them in the coming years!
Basic Research Fellows
Julien Bertrand, PhD
University of California, San Diego
Ontogeny of definitive hematopoiesis in the zebrafish
Anil Chauhan, PhD
Immune Disease Institute
Role of the VWF-cleaving protease ADAMTS13 in atherosclerosis and ischemic stroke
Sioban Keel, MD
University of Washington
Defining the pathophysiology of pure red cell aplasia due to Feline Leukemic Virus, subgroup C, Receptor (FLVCR) dysfunction
Simon Mendez-Ferrer, PhD
Mount Sinai School of Medicine
Neural regulation and function of a candidate mesenchymal stem cell forming the hematopoietic stem cell niche
Tammy Morrish, PhD
Johns Hopkins University
The molecular basis of telomere maintenance by recombination
Christopher Park, MD, PhD
Stanford University
Elucidating the role of microRNA-29a in acute myeloid leukemia stem cells and their normal counterparts
Ryan Phan, PhD
Immune Disease Institute
Generation of novel germinal center-derived B cell lymphoma models
Clinical/Translational Research Fellow
Rodger Tiedemann, MD, PhD
Mayo Clinic - Arizona
Chemo-sensitizing vulnerabilities in the druggable genome of multiple myeloma
Basic Research Junior Faculty
Wolfgang Bergmeier, PhD
Thomas Jefferson University
Role of CalDAG-GEFI in Ca2+ -dependent platelet activation
Todd Fehniger, MD, PhD
Washington University, St. Louis
The Role of microRNAs in the Regulation of Natural Killer Cell Cytokine Activation
Ivan Maillard, MD, PhD
University of Michigan
Regulation of allogeneic CD4+ and CD8+ T cell responses by Notch signaling
Alexander Minella, MD
Northwestern University
Deregulated cyclin E in the pathogenesis of myelodysplasia and leukemia
Clinical/Translational Research Junior Faculty
Naoto Hirano, MD, PhD
Dana-Farber Cancer Institute
Tipping the balance between autoreactive T cells and IL-10 secreting regulatory T cells in immune-mediated aplastic anemia
Allison King, MD, MPH
Washington University, St. Louis
Expansion of randomized educational rehabilitation trial for students with sickle cell disease and memory deficits
Vivian Oehler, MD
Fred Hutchinson Cancer Research Center
Progression and resistance in chronic myeloid leukemia
2008-2010 Scholars
Below are the Scholar Awardees being supported from July 1, 2008, to June 30, 2010.
Basic Research Fellows
Silva Buonamici, PhD
New York University
The NF-kB and Notch1 pathways in the pathogenesis of T-cell acute lymphoblastic leukemia
Xuefang Cao, PhD
Roswell Park Cancer Institute
Mechanisms of tumor-induced regulatory T-cell activation and function
Kira Gritsman, MD, PhD
Dana-Farber Cancer Institute
Role of the PI3 Kinase/AKT pathway in hematopoiesis and leukemia
Jeanne Henderickson, MD
Emory University
Regulation of red blood cell alloimmunization in different subtypes of recipient inflammation
Han Liu, PhD
Washington University
The role of MLL in DNA damage checkpoint and its implication in leukemogenesis
Shannon McKinney-Freeman, PhD
Children's Hospital Boston
Characterization of embryonic stem cell-derived hematopoietic stem cells
Akil Merchant, MD
John Hopkins University
The hedgehog signaling pathway in normal and malignant hematopoiesis
Charles Mullighan, MBBS, MD, MSc
St. Jude Children’s Research Hospital
High-resolution and genomic epigenetic analysis of acute lymphoblastic leukemia
Eric S. Mullins, MD
Cincinnati Children’s Hospital
Thrombin and thrombin targets in allergic airway inflammation
Matthew Strout, MD, PhD
Yale University
Targeting of activation induced cytidine deaminase during somatic hypermutation
Clinical/Translational Research Fellows
Elizabeth Hexner, MD
University of Pennsylvania
Predictors of therapeutic responsiveness to CEP-701 in myelofibrosis
Joshua Schiffman, MD
University of Utah
Novel genomic approach for risk-stratification of childhood leukemia
Geoffrey L. Uy, MD
Washington University
Targeting the CXCR4-SDF-1 axis as treatment for relapsed/refractory AML
Jing Yang, PhD
University of Texas M. D. Anderson Cancer Center
Targeting β2-microglobulin for induction of tumor apoptosis in myeloma
Basic Research Junior Faculty
Natalia Beglova, PhD
Beth Israel Deaconess Medical Center
Structural and functional studies of β2GPI complexes with the LDLR family receptors
L.R. Devireddy, DVM, PhD
Case Western Reserve University
Role of lipocalin 24p3 in apoptosis and myeloproliferative disease
Takahiro Maeda, MD, PhD
City of Hope National Medical Center
Role of the proto-oncogene LRF in normal B-cell development and lymphomagenesis
David Motto, MD, PhD
University of Iowa
Mechanisms of shared pathophysiology between TTP and HUS
Cindy N. Roy, PhD
Johns Hopkins University
Regulation of erythropoiesis in inflammation and frailty
Loren Walensky, MD, PhD
Dana-Farber Cancer Institute
Chemical dissection of the molecular trigger mechanisms for BAX-induced apoptosis
Zack Wang, PhD
Maine Medical Center
EphB4 regulation of hematopoietic and endothelial progenitor cell fate
David C. Williams Jr., MD, PhD
VCU Health System
Developing a methyl cytosine-binding protein complex as a molecular therapeutic target
Chengcheng Zhang, PhD
University of Texas Southwestern Medical Center
The role of angiopoietin-like proteins in expansion of hematopoietic stem cells
Clinical/Translational Research Junior Faculty
Heidi Klepin, MD (ASP-ASH Geriatric Hematology Research Award Scholar)
Wake Forest University
Investigating the relationship between physical function, comorbidity, cytogenetic risk group, and prognosis in older adults with acute myelogenous leukemia
2007-2009 Scholars
Below are the Scholar Awardees being supported from July 1, 2007, to June 30, 2009.
Basic Research Fellows
Larry D. Bozulic, PhD
University of Louisville
Nonmyeloblative conditioning to establish induction of islet transplants
Jalila Chagraoui, PhD
Institute for Research in Immunology and Cancer
Regulation of HSC self-renewal by Bmi1 and associated proteins
Francesca Ficara, PhD
Stanford University
Role of the PBX1 proto-oncogene in the regulation of adult hematopoieis
Maria E. Figueroa, MD
Albert Einstein College of Medicine of Yeshiva University
An integrative genetic and epigenetic characterization of normal karyotype acute myeloid leukemia (AML)
Tobias Ragoczy, PhD
Fred Hutchinson Cancer Research Center
Peripheral localization and regulation of the murine B-globin locus
Clinical/Translational Research Fellows
Dan Vogl, MD
University of Pennsylvania School of Medicine
Individualization of high-dose melphalan for myeloma: Effect of obesity and renal function on melphalan pharmacokinetics
Basic Research Junior Faculty
Paul J. Galardy, MD
Mayo Clinic
De-ubiquitination and the IL-2 response: An in vivo approach
Hanno Hock, MD, PhD
Massachusetts General Hospital
Zinc finger transcriptional repressor Gfi-1 in stem cells of normal hematopoiesis and leukemia
Hanna Mikkola, MD, PhD
The Regents of the University of California
Mouse models for defining hematopoietic stem cell development in the placenta
Emmanuelle A. Passegue, PhD
University of California, San Francisco
Role of JunB in leukemic stem cell transformation: Implications for myeloid leukemia and targeted therapy
Ethan J. Weiss, MD
University of California, San Francisco
Sex differences in hemostasis and thrombosis in mice: The role of the growth
Clinical/Translational Research Junior Faculty
David Miklos, MD, PhD
Stanford University
Allogeneic B-cell responses and chronic GVHD after hematopoietic cell transplantation
Sattva Neelapu, MD
University of Texas M. D. Anderson Cancer Center
Identification of novel tumor-associated antigens in follicular lymphoma